Yujun Du

559 total citations
24 papers, 386 citations indexed

About

Yujun Du is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yujun Du has authored 24 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Yujun Du's work include Dialysis and Renal Disease Management (6 papers), Chronic Kidney Disease and Diabetes (4 papers) and Parathyroid Disorders and Treatments (3 papers). Yujun Du is often cited by papers focused on Dialysis and Renal Disease Management (6 papers), Chronic Kidney Disease and Diabetes (4 papers) and Parathyroid Disorders and Treatments (3 papers). Yujun Du collaborates with scholars based in China. Yujun Du's co-authors include Xiujiang Li, Yue Hou, Xuejiao Wei, Lili Jiang, Liguang Sun, Xiaoyu Zhu, Lizhi Yang, Qingfei Xiao, Hongbin Zou and Fan Yang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Life Sciences.

In The Last Decade

Yujun Du

23 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yujun Du China 11 200 71 68 50 46 24 386
Ernesto Rodríguez Ayala Sweden 7 157 0.8× 36 0.5× 74 1.1× 62 1.2× 125 2.7× 9 419
Kunimi Maeda Japan 11 131 0.7× 29 0.4× 44 0.6× 37 0.7× 52 1.1× 35 359
William K.W. Cheung Hong Kong 11 126 0.6× 23 0.3× 57 0.8× 54 1.1× 101 2.2× 21 426
Fatemeh Hayati Iran 10 172 0.9× 60 0.8× 87 1.3× 70 1.4× 43 0.9× 26 385
Emanuela Cecchin Italy 10 90 0.5× 55 0.8× 53 0.8× 47 0.9× 51 1.1× 19 447
Meital Cohen-Mazor Israel 8 81 0.4× 35 0.5× 76 1.1× 73 1.5× 45 1.0× 10 413
L G Downs United Kingdom 10 119 0.6× 54 0.8× 58 0.9× 115 2.3× 57 1.2× 16 463
Anna Jovanovich United States 13 257 1.3× 46 0.6× 159 2.3× 67 1.3× 73 1.6× 28 502
Santao Ou China 10 165 0.8× 53 0.7× 79 1.2× 118 2.4× 40 0.9× 47 408
Itsuko Miyazawa Japan 11 92 0.5× 47 0.7× 81 1.2× 79 1.6× 102 2.2× 36 450

Countries citing papers authored by Yujun Du

Since Specialization
Citations

This map shows the geographic impact of Yujun Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujun Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujun Du more than expected).

Fields of papers citing papers by Yujun Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujun Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujun Du. The network helps show where Yujun Du may publish in the future.

Co-authorship network of co-authors of Yujun Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yujun Du. A scholar is included among the top collaborators of Yujun Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujun Du. Yujun Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Xuejiao, Xiaoyu Zhu, Ling Tian, et al.. (2025). Unveiling the therapeutic potential of berberine: its therapeutic role and molecular mechanisms in kidney diseases. Frontiers in Pharmacology. 16. 1549462–1549462. 7 indexed citations
2.
Wei, Xuejiao, et al.. (2024). Correlation between soluble klotho and chronic kidney disease–mineral and bone disorder in chronic kidney disease: a meta-analysis. Scientific Reports. 14(1). 4477–4477. 7 indexed citations
3.
Wei, Xuejiao, et al.. (2024). Whole-body water mass and kidney function: a Mendelian randomization study. Frontiers in Endocrinology. 15. 1336142–1336142.
4.
Wei, Xuejiao, et al.. (2021). Recent research progress on the role of ulinastatin in chronic kidney disease. Nephrology. 26(9). 708–714. 9 indexed citations
5.
Zhu, Xiaoyu, et al.. (2021). Metabolic Reprogramming and Renal Fibrosis. Frontiers in Medicine. 8. 746920–746920. 36 indexed citations
6.
Zhang, Guo‐Xing, Yujun Du, Yu Sun, et al.. (2020). Ulinastatin enhances autophagy against radiation-induced lung injury in mice. Translational Cancer Research. 9(7). 4162–4172. 5 indexed citations
7.
Zhang, Guolin, et al.. (2018). Protective effect of erythropoietin against lipopolysaccharide induced inflammation and mitochondrial damage in liver.. PubMed. 32(2). 199–206. 6 indexed citations
8.
Sun, Liguang, Yue Hou, Qingfei Xiao, & Yujun Du. (2017). Association of serum sodium and risk of all-cause mortality in patients with chronic kidney disease: A meta-analysis and sysematic review. Scientific Reports. 7(1). 15949–15949. 43 indexed citations
9.
Hou, Yue, Xiujiang Li, Liguang Sun, et al.. (2017). Phosphorus and mortality risk in end-stage renal disease: A meta-analysis. Clinica Chimica Acta. 474. 108–113. 31 indexed citations
10.
Liu, Zhi, Yudan Wei, Yue Hou, et al.. (2016). Differences in pathological characteristics and laboratory indicators in adult and pediatric patients with Henoch-Schönlein purpura nephritis. Journal of Huazhong University of Science and Technology [Medical Sciences]. 36(5). 659–666. 3 indexed citations
11.
Jiang, Yanfang, et al.. (2016). Characteristics of CD4+CD25+Foxp3+ regulatory T cells in patients with multiple organ dysfunction syndrome. Experimental and Therapeutic Medicine. 11(5). 1908–1912. 3 indexed citations
12.
Sun, Yu, et al.. (2016). Protective effects of ulinastatin and methylprednisolone against radiation-induced lung injury in mice. Journal of Radiation Research. 57(5). 505–511. 7 indexed citations
13.
Wei, Yudan, Jing Lin, Fan Yang, et al.. (2016). Risk factors associated with secondary hyperparathyroidism in patients with chronic kidney disease. Experimental and Therapeutic Medicine. 12(2). 1206–1212. 10 indexed citations
14.
Liu, Zhi, Yudan Wei, Xiujiang Li, et al.. (2015). Decreased number of CD14+TLR4+ monocytes and their impaired cytokine responses to lipopolysaccharide in patients with chronic kidney disease. Journal of Huazhong University of Science and Technology [Medical Sciences]. 35(2). 206–211. 7 indexed citations
15.
Zhang, Honghao, et al.. (2015). Analysis of the correlation between serum resistin and the variability of erythropoietin responsiveness in patients with chronic kidney disease. Experimental and Therapeutic Medicine. 10(5). 1925–1930. 5 indexed citations
16.
Yang, Fan, Li Zhang, Hao Wu, Hongbin Zou, & Yujun Du. (2014). Clinical Analysis of Cause, Treatment and Prognosis in Acute Kidney Injury Patients. PLoS ONE. 9(2). e85214–e85214. 34 indexed citations
17.
Hou, Yue, Xiujiang Li, Lizhi Yang, et al.. (2014). Factors associated with depression and anxiety in patients with end-stage renal disease receiving maintenance hemodialysis. International Urology and Nephrology. 46(8). 1645–1649. 40 indexed citations
18.
Du, Yujun, Xiujiang Li, & Bin Liu. (2013). Advances in pathogenesis and current therapeutic strategies for cardiorenal syndrome. Life Sciences. 99(1-2). 1–6. 7 indexed citations
19.
Li, Xiujiang, et al.. (2013). Protective effects of erythropoietin on endotoxin-related organ injury in rats. Journal of Huazhong University of Science and Technology [Medical Sciences]. 33(5). 680–686. 18 indexed citations
20.
Hou, Yue, Xiujiang Li, Hongbin Zou, et al.. (2012). Comparison of different assessments for evaluating malnutrition in Chinese patients with end-stage renal disease with maintenance hemodialysis. Nutrition Research. 32(4). 266–271. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026